Prof. Masashi Yanagisawa, University of Tsukuba
14:40 JST, September 20, 2023
Tokyo, Sept. 19 (Jiji Press)—Japanese researchers Masashi Yanagisawa and Kazunori Kataoka are in the list of 23 world-class researchers named by Clarivate PLC as Citation Laureates for 2023, the international information provider said Tuesday.
Yanagisawa, 63, was chosen in the category of physiology or medicine, and Kataoka, 72, in the chemistry category.
Clarivate names researchers as Citation Laureates if they have made Nobel Prize-level research achievements and their papers are cited frequently. Citation Laureates often win a Nobel Prize.
Yanagisawa, director of the International Institute for Integrative Sleep Medicine at the University of Tsukuba in Ibaraki Prefecture, has contributed to the elucidation of the mechanism of sleep and wakening through the discovery of the wake-promoting substance orexin.
Kataoka, director-general of the Innovation Center of NanoMedicine at the Kawasaki Institute of Industrial Promotion in Kanagawa Prefecture, has developed a method to deliver drugs and genes targeting only specific cells, such as cancer cells, by combining them with special molecules.
"Science & Nature" POPULAR ARTICLE
-
Mass Oyster Die-Offs Confirmed in Japan’s Seto Inland Sea; High Water Temperature Cited as Primary Cause
-
Researchers in U.S., Japan Offer Insight into Ghostly Neutrinos
-
Big Leap in Quest to Get to Bottom of Climate Ice Mystery
-
Security Camera Footage Vulnerable to Outside Access; Investigation Finds 3,000 Pieces Exposed Online
-
Japan Plans to Develop System of AI Evaluating Credibility of Other AI Models
JN ACCESS RANKING
-
Govt Plans to Urge Municipalities to Help Residents Cope with Rising Prices
-
Japan Prime Minister Takaichi Vows to Have Country Exit Deflation, Closely Monitor Economic Indicators
-
Japan to Charge Foreigners More for Residence Permits, Looking to Align with Western Countries
-
Japan GDP Down Annualized 1.8% in July-Sept.
-
JR East Suica’s Penguin to Retire at End of FY2026; Baton to be Passed to New Character

